125 related articles for article (PubMed ID: 29762078)
1. Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Yang Z; Meng Q; Zhao Y; Han R; Huang S; Li M; Wu X; Cai W; Wang H
J Interferon Cytokine Res; 2018 Jun; 38(6):261-271. PubMed ID: 29762078
[TBL] [Abstract][Full Text] [Related]
2. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
[TBL] [Abstract][Full Text] [Related]
3. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
Ma B; Chen K; Liu P; Li M; Liu J; Sideras K; Sprengers D; Biermann K; Wang W; IJzermans JNM; Cao W; Kwekkeboom J; Peppelenbosch MP; Pan Q
J Mol Med (Berl); 2019 Jan; 97(1):77-88. PubMed ID: 30456450
[TBL] [Abstract][Full Text] [Related]
4. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
5. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Chai R; Fu H; Zheng Z; Liu T; Ji S; Li G
Mol Med Rep; 2017 Dec; 16(6):8037-8044. PubMed ID: 28983625
[TBL] [Abstract][Full Text] [Related]
7. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
Hung WC; Chuang LY
Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
[TBL] [Abstract][Full Text] [Related]
9. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
10. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.
Yin L; Fang Z; Shen NJ; Qiu YH; Li AJ; Zhang YJ
Drug Des Devel Ther; 2017; 11():2841-2850. PubMed ID: 29033545
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
13. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K
Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.
Ding H; Liu J; Liu B; Zeng Y; Chen P; Su Y
Biochem Biophys Res Commun; 2018 Jun; 500(4):973-980. PubMed ID: 29715456
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
[TBL] [Abstract][Full Text] [Related]
17. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma.
Dong L; Wei X; Yu L; Li Y; Chen L
Cell Signal; 2024 Feb; 114():111005. PubMed ID: 38070755
[TBL] [Abstract][Full Text] [Related]
19. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
[TBL] [Abstract][Full Text] [Related]
20. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
